MGC Diagnostics (MGCD) Reports Q3 EPS of $0.80

MGC Diagnostics (NASDAQ: MGCD) reported Q3 EPS of $0.80, versus ($0.21) reported last year. Revenue for the quarter came in at $9.24 million, versus $6.6 million reported last year.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• Four key things investors will watch in Nvidia's earnings next week
• Annexon, Inc. (ANNX) Misses Q2 EPS by 4c
• Ituran Location & Control (ITRN) Tops Q2 EPS by 6c